627 related articles for article (PubMed ID: 33766136)
1. Functional analysis of SARS-CoV-2 proteins in Drosophila identifies Orf6-induced pathogenic effects with Selinexor as an effective treatment.
Zhu JY; Lee JG; van de Leemput J; Lee H; Han Z
Cell Biosci; 2021 Mar; 11(1):59. PubMed ID: 33766136
[TBL] [Abstract][Full Text] [Related]
2. Characterization of SARS-CoV-2 proteins reveals Orf6 pathogenicity, subcellular localization, host interactions and attenuation by Selinexor.
Lee JG; Huang W; Lee H; van de Leemput J; Kane MA; Han Z
Cell Biosci; 2021 Mar; 11(1):58. PubMed ID: 33766124
[TBL] [Abstract][Full Text] [Related]
3. Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice.
Silvas JA; Vasquez DM; Park JG; Chiem K; Allué-Guardia A; Garcia-Vilanova A; Platt RN; Miorin L; Kehrer T; Cupic A; Gonzalez-Reiche AS; Bakel HV; García-Sastre A; Anderson T; Torrelles JB; Ye C; Martinez-Sobrido L
J Virol; 2021 Aug; 95(17):e0040221. PubMed ID: 34133899
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 ORF6 protein does not antagonize interferon signaling in respiratory epithelial Calu-3 cells during infection.
Li M; Ayyanathan K; Dittmar M; Miller J; Tapescu I; Lee JS; McGrath ME; Xue Y; Vashee S; Schultz DC; Frieman MB; Cherry S
mBio; 2023 Aug; 14(4):e0119423. PubMed ID: 37377442
[TBL] [Abstract][Full Text] [Related]
5. Nucleopore Traffic Is Hindered by SARS-CoV-2 ORF6 Protein to Efficiently Suppress IFN-β and IL-6 Secretion.
Gori Savellini G; Anichini G; Gandolfo C; Cusi MG
Viruses; 2022 Jun; 14(6):. PubMed ID: 35746745
[TBL] [Abstract][Full Text] [Related]
6. Drosophila, a powerful model to study virus-host interactions and pathogenicity in the fight against SARS-CoV-2.
van de Leemput J; Han Z
Cell Biosci; 2021 Jun; 11(1):110. PubMed ID: 34120640
[TBL] [Abstract][Full Text] [Related]
7. Selinexor, a novel selective inhibitor of nuclear export, reduces SARS-CoV-2 infection and protects the respiratory system in vivo.
Kashyap T; Murray J; Walker CJ; Chang H; Tamir S; Hou B; Shacham S; Kauffman MG; Tripp RA; Landesman Y
Antiviral Res; 2021 Aug; 192():105115. PubMed ID: 34157321
[TBL] [Abstract][Full Text] [Related]
8. Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis.
Kehrer T; Cupic A; Ye C; Yildiz S; Bouhhadou M; Crossland NA; Barrall E; Cohen P; Tseng A; Çağatay T; Rathnasinghe R; Flores D; Jangra S; Alam F; Mena N; Aslam S; Saqi A; Marin A; Rutkowska M; Ummadi MR; Pisanelli G; Richardson RB; Veit EC; Fabius JM; Soucheray M; Polacco BJ; Evans MJ; Swaney DL; Gonzalez-Reiche AS; Sordillo EM; van Bakel H; Simon V; Zuliani-Alvarez L; Fontoura BMA; Rosenberg BR; Krogan NJ; Martinez-Sobrido L; García-Sastre A; Miorin L
bioRxiv; 2022 Nov; ():. PubMed ID: 36299428
[TBL] [Abstract][Full Text] [Related]
9. Understanding Individual SARS-CoV-2 Proteins for Targeted Drug Development against COVID-19.
van de Leemput J; Han Z
Mol Cell Biol; 2021 Aug; 41(9):e0018521. PubMed ID: 34124934
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive Drosophila resource to identify key functional interactions between SARS-CoV-2 factors and host proteins.
Guichard A; Lu S; Kanca O; Bressan D; Huang Y; Ma M; Sanz Juste S; Andrews JC; Jay KL; Sneider M; Schwartz R; Huang MC; Bei D; Pan H; Ma L; Lin WW; Auradkar A; Bhagwat P; Park S; Wan KH; Ohsako T; Takano-Shimizu T; Celniker SE; Wangler MF; Yamamoto S; Bellen HJ; Bier E
Cell Rep; 2023 Aug; 42(8):112842. PubMed ID: 37480566
[TBL] [Abstract][Full Text] [Related]
11. Interferon antagonism by SARS-CoV-2: a functional study using reverse genetics.
Schroeder S; Pott F; Niemeyer D; Veith T; Richter A; Muth D; Goffinet C; Müller MA; Drosten C
Lancet Microbe; 2021 May; 2(5):e210-e218. PubMed ID: 33969329
[TBL] [Abstract][Full Text] [Related]
12. Phage display technique identifies the interaction of severe acute respiratory syndrome coronavirus open reading frame 6 protein with nuclear pore complex interacting protein NPIPB3 in modulating Type I interferon antagonism.
Huang SH; Lee TY; Lin YJ; Wan L; Lai CH; Lin CW
J Microbiol Immunol Infect; 2017 Jun; 50(3):277-285. PubMed ID: 26320399
[TBL] [Abstract][Full Text] [Related]
13. The importance of accessory protein variants in the pathogenicity of SARS-CoV-2.
Hassan SS; Choudhury PP; Dayhoff GW; Aljabali AAA; Uhal BD; Lundstrom K; Rezaei N; Pizzol D; Adadi P; Lal A; Soares A; Mohamed Abd El-Aziz T; Brufsky AM; Azad GK; Sherchan SP; Baetas-da-Cruz W; Takayama K; Serrano-Aroca Ã; Chauhan G; Palu G; Mishra YK; Barh D; Santana Silva RJ; Andrade BS; Azevedo V; Góes-Neto A; Bazan NG; Redwan EM; Tambuwala M; Uversky VN
Arch Biochem Biophys; 2022 Mar; 717():109124. PubMed ID: 35085577
[TBL] [Abstract][Full Text] [Related]
14. Insights into the SARS-CoV-2 ORF6 Mechanism of Action.
Krachmarova E; Petkov P; Lilkova E; Ilieva N; Rangelov M; Todorova N; Malinova K; Hristova R; Nacheva G; Gospodinov A; Litov L
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511350
[TBL] [Abstract][Full Text] [Related]
15. Interferon-
Krachmarova E; Petkov P; Lilkova E; Stoynova D; Malinova K; Hristova R; Gospodinov A; Ilieva N; Nacheva G; Litov L
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396843
[TBL] [Abstract][Full Text] [Related]
16. Decoupling SARS-CoV-2 ORF6 localization and interferon antagonism.
Wong HT; Cheung V; Salamango DJ
J Cell Sci; 2022 Mar; 135(6):. PubMed ID: 35187564
[TBL] [Abstract][Full Text] [Related]
17. Molecular Mechanism of SARS-CoVs Orf6 Targeting the Rae1-Nup98 Complex to Compete With mRNA Nuclear Export.
Li T; Wen Y; Guo H; Yang T; Yang H; Ji X
Front Mol Biosci; 2021; 8():813248. PubMed ID: 35096974
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists.
Yuen CK; Lam JY; Wong WM; Mak LF; Wang X; Chu H; Cai JP; Jin DY; To KK; Chan JF; Yuen KY; Kok KH
Emerg Microbes Infect; 2020 Dec; 9(1):1418-1428. PubMed ID: 32529952
[TBL] [Abstract][Full Text] [Related]
19. Severe Acute Respiratory Syndrome Coronavirus ORF7a Inhibits Bone Marrow Stromal Antigen 2 Virion Tethering through a Novel Mechanism of Glycosylation Interference.
Taylor JK; Coleman CM; Postel S; Sisk JM; Bernbaum JG; Venkataraman T; Sundberg EJ; Frieman MB
J Virol; 2015 Dec; 89(23):11820-33. PubMed ID: 26378163
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 ORF6 disrupts nucleocytoplasmic trafficking to advance viral replication.
Miyamoto Y; Itoh Y; Suzuki T; Tanaka T; Sakai Y; Koido M; Hata C; Wang CX; Otani M; Moriishi K; Tachibana T; Kamatani Y; Yoneda Y; Okamoto T; Oka M
Commun Biol; 2022 May; 5(1):483. PubMed ID: 35590097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
